Gan and Lee Pharmaceuticals, U
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (28)
Gan & Lee Insulin Glargine Target Type (1) Evaluating Research
Started: 10/31/2017
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Started: 10/31/2017
Gan & Lee Evaluation of New Biosimilar for Type 1 Lispro
Started: 12/4/2019
A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injection OD
Started: 6/28/2024
A Study of GZR18 Injection in Obese/Overweight Patients
Started: 6/8/2023
Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants
Started: 2/12/2025
A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Diabetes Mellitus
Started: 8/11/2023
A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DM
Started: 11/21/2023
Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State
Started: 10/13/2025
Comparison Study of Insulin GZR4 With Insulin Degludec
Started: 8/15/2025
A Study of GZR4 Injection at Different Injection Sites
Started: 5/8/2024
Pharmacokinetics and Safety Profile of a Single Dose GZR4 in Subjects with Renal Impairment
Started: 7/3/2024
A Phase I Clinical Study to Evaluate the Effect of GZR18 Injection on the Pharmacokinetics of Oral Metformin Hydrochloride Tablets in Overweight/Obese Subjects
Started: 10/30/2024
A Study to Evaluate the Safety, Tolerance, PK and PD Parameters of GZR33 and GZR101 in Healthy Male Adult Subjects
Started: 6/30/2022
A Clinical Study of GZR33 and GZR101 in Healthy Subjects
Started: 12/17/2022
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GZR4 in Subjects With Type 2 Diabetes
Started: 3/22/2023
A Study of GZR18 Tablet in Chinese Healthy Subjects
Started: 4/1/2024
A Phase I Study of GZR18 Injection in Healthy Subjects
Started: 12/2/2021
A Phase I Study of GZR18 Injection in Obese/Overweight Subjects
Started: 4/25/2023
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single-dose GZR4
Started: 8/29/2022
A Study of GZR18 Injection in Chinese Obese/Overweight Patients
Started: 7/14/2022
A Study of GZR18 Injection in Chinese Adult Patients With Type 2 Diabetes Mellitus (T2DM)
Started: 6/29/2022
Single, Ascending Dose, First Time in Human Study for GZR18 in Healthy Subjects
Started: 3/8/2022
PK/PD Study of Gan & Lee Insulin Aspart Injection vs. US & EU NovoLog®/NovoRapid® in Healthy Males
Started: 8/27/2019
PK/PD Biosimilarity Study of Gan & Lee Insulin Lispro Injection vs. EU and US Humalog® in Healthy Males
Started: 4/23/2019
PK/PD Biosimilarity Study of Gan & Lee Insulin Glargine Injection vs.US & EU Lantus® in Type 1 Diabetes Mellitus Patients
Started: 7/10/2018
PK/PD Study of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Type 1 Diabetes
Started: 12/1/2015